National Edition |
Test in Show
The Cue allows users to access incredibly deep health data from home
We’ve seen a lot of amazing, cool, and slick gadgets on the Upgrade beat, but the new device from Cue might just be the first that makes us feel like we’re living in the future.
Cue lets users access molecular level data from their bodies in minutes, from their home. Via saliva, a drop of blood, or nasal swab, the device can measure five major indicators – inflammation, vitamin D levels, fertility, the presence of influenza, and testosterone.
The company was founded in 2009, during the height of the swine flu panic. “The pandemic really brought out the idea that there’s this gap between the information people are seeking, and the ability for people to get that information,” cofounder and CPO Clint Sever told us. “All they wanted was an answer to ‘Do I have the flu or not?’ but it wasn’t simply accessible to them.”
Based out of San Francisco, Cue closed a $7.5 million Series A round in November. They anticipate shipping the device in summer 2015.
The Cue will run $199 and be available for purchase once the device receives FDA approval. You can get on the wait list for a Cue here.
They’re also hiring a mobile developer and lab tech – you can get the details here.
Now go forth (and welcome to the future).
Sign up for Uncubed Daily to receive the best tech news, career advice, and jobs.